Board of directors
Dr. Tracy Webb
Dr. Scott Hopper
Dr. Laurie Goodrich
Dr. Laurie Goodrich is the Interim Director of the Orthopedic Research Center at Colorado State University’s C. Wayne McIlwraith Translational Medicine Institute and an Equine Surgeon specializing in orthopedic surgery and lameness with a focus on musculoskeletal injuries and trauma. She is an American College of Veterinary Surgeons (ACVS) Founding Fellow in Minimally Invasive Surgery in Arthroscopy, Tenoscopy, and Fracture Repair. She received her DVM from the University of Illinois, completed an internship at Virginia Tech Regional College of Veterinary Medicine and an equine surgical residency at the Marion DuPont Scott Equine Medical Center in Northern Virginia. During that time, she also completed a Master of Science in Pharmacology at Virginia Tech. She joined the faculty at Cornell University as an Equine Surgeon in 1996 and also completed a PhD in cartilage repair in 2005 while at Cornell. She joined the faculty at CSU in 2005 as an Assistant Professor of Equine Surgery and is currently a Professor of Surgery and a principle investigator in the Orthopedic Research Center. She is a translational scientist whose research focuses on regenerative medicine, gene therapies and biologics to improve joint and bone repair in both animals and people. She has received the Elastikon Award in Research Excellence from the Grayson Jockey Club Research Foundation, the Cabaud Award in Research from AOSSM and CSU’s AAEP Clinician of the Year Award for teaching excellence. She is currently president of ACVS, on the Board of Directors for North American Veterinary Regenerative Medicine Association, and is the chair-elect for the Preclinical Models Section of the Orthopedic Research Society.
Dr. Thomas G. Koch
Immediate Past Chair
Dr. Susan W. Volk
Dr. Dean Betts
Dr. Boaz Arzi
Dr. Boaz Arzi is a professor of dentistry and oral surgery at the department of Surgical and Radiological Sciences, UC Davis School of Veterinary Medicine. Dr. Arzi completed the residency-training program in dentistry and oral surgery at the school and two years fellowship in the UC Davis Department of Biomedical Engineering. He is a Diplomate of the American Veterinary Dental College (AVDC) and the European Veterinary Dental College. Dr. Arzi is also a Founding Fellow of the AVDC in Oral and Maxillofacial Surgery. Dr. Arzi’s clinical and research focus is on oral maxillofacial disorders and regenerative solutions in dogs and cats. His lab also investigates TMJ disorders and treatments across species. He is a co-principal investigator on the use of adipose-derived mesenchymal stem cells (MSC) for feline gingivostomatitis and also a co-principal investigator on the use of rhBMP-2 for mandibular reconstruction. Furthermore, Dr. Arzi works in collaboration with the biomedical engineering group at UC Davis for the development of biological solutions to TMJ disorders in humans. Dr. Arzi is the director of the school’s Veterinary Institute for Regenerative Cures (VIRC). Ultimately, Dr. Arzi’s work is translational with the aim of One Health treatment modalities for both human and animal health.
Dr. Ashlee Watts
Dr. Michael Kallos
Dr. Michael Kallos is a Professor in the Department of Chemical and Petroleum Engineering, Schulich School of Engineering, an Adjunct in the Department of Cell Biology and Anatomy in the Cumming School of Medicine, and Associate Director of the Pharmaceutical Production Research Facility (PPRF), all at the University of Calgary. He is the Director of the Biomedical Engineering (BME) Calgary Initiative and Associate Director of the Center for Bioengineering Research and Education (CBRE), as well as a member of the McCaig Institute for Bone and Joint Health. The Biomedical Engineering Calgary Initiative at the University of Calgary, brings together over 300 researchers from multiple faculties across campus to tackle problems in human and animal health and wellness. He is a Professional Engineer registered with APEGA. His research interests lie in the area of stem cell bioprocess engineering, including working with ESCs, iPSCs, MSCs and NSCs. He bases his research on a strong foundation in mass transfer, reactor design, reaction kinetics, fluid dynamics and experience in both experimental and modeling approaches. These fundamentals are key to the industrial/clinical scale-up and production of cell and biomaterial therapies.
Dr. Amir Kol
Dr. Amir Kol is an Assistant Professor at the Department of Pathology, Microbiology and Immunology and the University of California, Davis. He is a Diplomate of the American College of Veterinary Pathologists and a Ph.D in Integrative Pathobiology. Dr. Kol has graduate from the Koret School of Veterinary Medicine at the Hebrew University of Jerusalem, Israel in 2006. Amir’s research interests is in stem cell biology and its application to translational veterinary regenerative medicine and disease modeling. On going project at the Kol lab include 1) immunomodulatory properties of mesenchymal stem cells in the context of inflammatory and viral diseases, 2) canine stem cell pluripotency mechanisms and regulators and 3) intestinal stem cells-derived organoids as a disease in vitro model system. Amir is also interested in the potential key role that naturally occurring diseases in companion animals may play to inform human clinical trials in the process of novel drug/medical device development.
2021: Tracy L. Webb, DVM, PhD
2020: Tracy L. Webb, DVM, PhD
2019: Thomas G. Koch, DVM, PhD
2018: Kurt D. Hankenson, DVM, PhD
2017: Alan J. Nixon, BVSc, MS
2016: Alan J. Nixon, BVSc, MS
2015: Jennifer G. Barrett, PhD, DVM
2014: Jennifer G. Barrett, PhD, DVM
2013: John Peroni, DVM, MS, DACVS
2012: John Peroni, DVM, MS, DACVS
2011: Gregory L. Ferraro, DVM
2010: NAVRMA founded – Gregory L. Ferraro, DVM, and Doug Herthel, DVM